XBIT
XBIT
NASDAQ · Biotechnology

Xbiotech Inc

$2.27
-0.01 (-0.44%)
As of Aug 15, 2:19 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +427.3% upside
Low Target $8.96
Average Target $11.97
High Target $15.34
Current Price $2.27
Current
$2.27
Target
$11.97
$8.96 $11.97 avg $15.34
Scenario Analysis
Bear Case
$8.96
294.7%
Low target
Base Case
$11.97
+427.3%
Avg target
Bull Case
$15.34
+575.8%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$3.61
-37.1% from high
52-Week Low
$2.09
+8.6% from low
Target vs 52W High
$11.97
+231.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.4%